1
Clinical Trials associated with Clusters of Autologous Dermal Fibroblasts(S.Biomedics)A Single Center, Randomized, Evaluator and Subject Blind, Placebo Controlled, Parallel, Phase 1/2 Study for the Anti-wrinkle Efficacy Assessment and Safety Evaluation by Treating Cluster of Autologous Dermal Fibroblasts, 3D-F in Patients With Bilateral Crow's Feet
This study is a phase 1/2 clinical trial to evaluate the safety and efficacy of administering clusters of autologous dermal fibroblasts to subjects with periorbital wrinkles on both sides.
If subjects who have signed the Informed consent form voluntarily are enrolled in this study, they will be tested for eligibility during the screening period. Subjects will visit the study site a total of 6 times while participating in this study. The subjects who meet the inclusion/exclusion criteria will receive a total of one dose of the IP (Visit 3). Then, the efficacy evaluation will be conducted at Visit 4 (Week 2), Visit 5 (Week 12), and Visit 6 (Week 24), and safety will also be evaluated at each visit.
100 Clinical Results associated with Clusters of Autologous Dermal Fibroblasts(S.Biomedics)
100 Translational Medicine associated with Clusters of Autologous Dermal Fibroblasts(S.Biomedics)
100 Patents (Medical) associated with Clusters of Autologous Dermal Fibroblasts(S.Biomedics)
100 Deals associated with Clusters of Autologous Dermal Fibroblasts(S.Biomedics)